cRGD-Peptide Modified Covalent Organic Frameworks for Precision Chemotherapy in Triple-Negative Breast Cancer
ACS Applied Materials & Interfaces · 23.10.2024 · 16 (42) · 56676-56695
DOI: 10.1021/acsami.4c10812 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 13.09.2024. Verfasst von Farah Benyettou und 16 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Program, New York University Abu Dhabi (NYUAD), Abu Dhabi 129188, United Arab Emirates. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Peptides, Cyclic, Doxorubicin, Metal-Organic Frameworks. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ASPIRE, New York University Abu Dhabi.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemistry Program, New York University Abu Dhabi (NYUAD), Abu Dhabi 129188, United Arab Emirates.
- Core Technology Platforms, New York University Abu Dhabi, 129188 Abu Dhabi, United Arab Emirates.
- Technology Innovative Institute, P.O. Box 9639, Abu Dhabi 9639, United Arab Emirates.
- Instituto de Ciencia de Materiales de Madrid-CSIC, C. Sor Juana Inés de La Cruz 3, Madrid 28049, Spain.
- Engineering Division, New York University Abu Dhabi, 129188 Abu Dhabi, United Arab Emirates.
- College of Pharmacy, Al Ain University, P.O. Box 112612, Abu Dhabi 112612, United Arab Emirates.
ORCID-Profile: Thirumurugan Prakasam, Pilar Pena-Sánchez, Jamie Whelan, Ramesh Jagannathan, Felipe Gándara, Ali Trabolsi
Förderung
- ASPIRE
- New York University Abu Dhabi
Zitieren
APA
Benyettou, F., Khair, M., Prakasam, T., Varghese, S., Matouk, Z., Alkaabi, M., Pena-Sánchez, P., Boitet, M., AbdulHalim, R., Sharma, S. K., Ghemrawi, R., Thomas, S., Whelan, J., Pasricha, R., Jagannathan, R., Gándara, F., & Trabolsi, A. (2024). cRGD-Peptide Modified Covalent Organic Frameworks for Precision Chemotherapy in Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces, 16(42), 56676-56695. https://doi.org/10.1021/acsami.4c10812
Vancouver
Benyettou F, Khair M, Prakasam T, Varghese S, Matouk Z, Alkaabi M, et al. cRGD-Peptide Modified Covalent Organic Frameworks for Precision Chemotherapy in Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces. 2024;16(42):56676-56695. doi:10.1021/acsami.4c10812
BibTeX
@article{Benyettou2024,
author = {Benyettou, Farah and Khair, Mostafa and Prakasam, Thirumurugan and Varghese, Sabu and Matouk, Zineb and Alkaabi, Maryam and Pena-Sánchez, Pilar and Boitet, Maylis and AbdulHalim, Rasha and Sharma, Sudhir Kumar and Ghemrawi, Rose and Thomas, Sneha and Whelan, Jamie and Pasricha, Renu and Jagannathan, Ramesh and Gándara, Felipe and Trabolsi, Ali},
title = {cRGD-Peptide Modified Covalent Organic Frameworks for Precision Chemotherapy in Triple-Negative Breast Cancer},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
volume = {16},
number = {42},
pages = {56676--56695},
doi = {10.1021/acsami.4c10812}
}
EUVIMED